Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab in Moderate to Severe Allergic Asthma
NCT00406965Phase 2Completed
- Sponsor
- Genentech
- Start
- Dec 2006
01
Overview
Phase 2, randomised, double-blind trial of lebrikizumab in allergic asthma, sponsored by Genentech. Started Dec 2006; status: completed.
02
Drugs
lebrikizumab
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00406965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406965.